John Connolly, Ph.D., interim CEO, and Hanspeter Gerber, Ph.D., Chief Scientific Officer, will participate in the BIO CEO & Investor Digital Conference, February 16-18, 2021. Dr. Connolly, will present an overview of the company and 3T-TRACE, a technology that applies a yeast display platform and active machine learning to identify novel targets and T-cell receptors (TCRs). More information is on the BIO CEO website including ways to access company presentations and register for the event. Company presentations will also be archived online and available for on-demand viewing.

3T At Bio Ceo Linkedin Graphic